03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Carmen Bozic
M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex
press citation on 1 topic since 12 Oct 2026 · last quoted 12 Oct 2026
02 Quoted on · 1 of 29 topics
Carmen Bozic: key facts
- Kind of voice
- Academic
- Role
- M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 12 Oct 2026
04 The signal · where Carmen Bozic sits on rare diseases
Ranked 31= of 100 voices quoted in the press on rare diseases, level with 69 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)5
- 2=
David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4 - 2=
Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4 - 31=Michael EpsteinSector leaderVice president, commercial strategy and pricing, Clinigen1
- 31=Susanne MichelSector leaderVice president, head of HTA methods and evidence planning, Clinigen1
- 31=Carmen BozicAcademicM.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex1
- 31=Chandrabali GhoseSector leaderChief scientific officer, Emily's Entourage1
- 31=Jennifer AndrewsClinicianPediatric hematologist and medical director of the blood bank at Vanderbilt University Medical Center1
Showing the leaders and the ranks around 31=, of 100 voices · See every voice on the topic →
05 On the record · press
What Carmen Bozic has said
- biospace.com1
Where Carmen Bozic has been quoted
- 01Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conferencebiospace.com · 12 Oct 2026
Verbatim
“For decades, pancreatic organ failure and resulting exocrine pancreatic insufficiency has been accepted as an irreversible consequence of CF, but these remarkable data in younger children treated with ALYFTREK show that, in fact, pancreatic failure can be reversed.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Rosie Huntington-Whiteley Wears The Backless Dress To End All Backless DressesVogue
- Husband and wife set up support group to help people live more positively with Motor Neurone DiseaseBlog Preston
- The British Ophthalmological Surveillance Unit: active surveillance of rare eye disease in the digital eraNature
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.